CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL · NEW YORK STOCK EXCHANGE INC.

Research and Development in Biotechnology · US

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

ESG Overview

Overall: BBB (High)

E: AS: BBG: B

ESG grades from public dataset.

ESG data: Public Company ESG Ratings (CC BY-NC-SA 4.0)

Market Data

Price $167.37 -9.62 (-5.44%)

Market Cap$8.71B

P/E Ratio—

EPS$—

52W High$228.88

52W Low$91.86

Beta1.62

Data from Finnhub · Updated Mar 10, 2026